Pfizer has encountered many setbacks in its quest to launch a medicine that could rival Wegovy and Zepbound. One of its ...

A new weight-loss pill taken daily could compete with injections like Ozempic, research suggests. Patients, who all were ...

Discover the effectiveness and safety of Mounjaro, the new weight loss drug launched in India. Learn from expert Dr. Pal ...

Cardio burns more calories per session, while weight training offers sustained metabolic benefits by building lean muscle.

Last year, the National Health Commission and other departments launched the "Weight Management Year" initiative, aiming to ...

Weight loss is challenging at the best of times, but the importance of forming sustainable habits cannot be overstated for ...

Patients with obesity often report being shamed and stigmatized in medical settings. How can physicians address weight ...

In Australia, Ozempic is approved for the treatment of type 2 diabetes, while Wegovy is approved for weight management. Both ...

After reviewing all the data and considering input from regulators, Pfizer decided to discontinue the danuglipron program.

Diabetics given the pill called orforglipron lost 16 pounds, or 7.9% of their body weight, over a 40-week period.

The mid-stage trial results announced by the pharmaceutical giant showed that patients taking orforglipron lost an average of ...

A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...